18th World Congress on Advances in Oncology
and
16th International Symposium on Molecular Medicine
October 10-12, 2013
Hotel Creta Maris Resort, Hersonissos, Crete, Greece
RECIPIENTS OF THE AWARDS OF THE BEST PRESENTATIONS
- 149. Gonocytes frozen in time: A look at the origins of testicular cancer. M. Culty (Montreal, Canada)
- 166. 11β-hydroxyandrostenedione is metabolised to novel androgenic C19 steroids in the prostate. A.C. Swart, L.M. Bloem, L. Schloms, P. Swart, D. Africander, K.-H. Storbeck (Stellenbosch, South Africa)
- 169. Colon cancer cell lipidome and dietary lipids. J. Hofmanová, A.H. Vaculová, Z. Tylichová, N. Straková, B. Skender, J. Slavík, M. Ciganek, M. Machala, A. Kozubík (Brno, Czech Republic)
- 187. The PKC-iota inhibitor ICA-1 combined with TRAIL for glioblastoma therapy. A.N. McCray, S. Desai, M. Acevedo-Duncan (Tampa, FL, USA)
- 198. Protective role of heme oxygenase-1/CO system in hemorrhagic shock-induced acute lung injury. T. Takahashi, S. Kawanishi, J. Kosaka, H. Shimizu, H. Morimatsu (Okayama, Japan)
- 221. Oncogene driven Redox signalling in tumour cells. T.G. Cotter, J. Stanicka, W. Landry (Cork, Ireland)
- 225. Association saquinavir-imatinib in the treatment of refractory neuroblastoma: A report of a single case. F. Timeus, E. Rivetti, S. Asaftei, M. Bianchi, C. Gabiano, P.A. Tovo, F. Fagioli (Turin, Italy)
- 232. New pharmacological approach by siRNA against junction oncogenes for thyroid and prostate cancers. G. Urbinati, A.M. Hafiz, L. Massaad-Massade (Villejuif, France)
- 257. Potential biomarkers for ovarian cancer. G. Xu (Shanghai, P.R. China)
- 261. Mechanisms controlling diversification and affinity maturation of antibodies. J. Hauser, J. Verma-Gaur, A. Wallenius, C. Grundström, T. Grundström (Umeå, Sweden)
- 279. Cellular immune regulation of GvL and GvHD following allogeneic stem cell transplantation. E. Ullrich (Frankfurt; Erlangen, Germany)
- 329. Differential effects of oxytocin in prostate cancer cell lines and de novo steroidogenesis. S. Assinder, A. Cole, K. Davies, M. Day, N. Tom (Sydney, Australia)
- 369. Modification of photodynamic therapy induced in cancer cells. J. Saczko, J. Wezgowiec, A. Choromanska, N. Rembialkowska, M. Dubinska-Magiera, M. Kotulska, K. Biezunska-Kusiak, J. Kulbacka (Wroclaw, Poland)
- 382. Tetraspanin CD81 contributes to melanoma invasion and metastasis by enhancing cell migrating ability through its positive effect on MT1-MMP expression. H. Lee, I.-K. Hong, H.-J. Byun (Chuncheon, Republic of Korea)
